Skip to main content
. 2015 Aug 21;6(34):36774–36788. doi: 10.18632/oncotarget.4908

Table 3. Patient characteristics (n = 144).

Feature Freq (%)
Gender (n = 144) Male 66 (45.8)
Female 78 (54.2)
Patient age (n = 144) (years) Mean ± SD 69.4 ± 11.5
Tumor size (n = 144) (cm) Mean ± SD 4.6 ± 2.0
Histological subtype (n = 144) Other 130 (90.3)
Mucinous 14 (9.7)
Tumor grade (n = 144) G1–2 97 (67.4)
G3 47 (32.6)
Tumor location (n = 144) Left 87 (60.4)
Rectum 18 (12.5)
Right 39 (27.1)
pT classification (n = 144) pT1–2 38 (26.4)
pT3–4 106 (73.6)
pN classification (n = 144) pN0 78 (54.2)
pN1–2 66 (45.8)
pM classification (n = 144) pM0 125 (86.8)
pM1 19 (13.2)
Venous invasion (n = 144) Present 27 (18.8)
Negative 117 (81.2)
Lymphatic invasion (n = 144) Present 57 (39.6)
Negative 87 (60.4)
Post-operative therapy (n = 144) None 57 (39.6)
Treated 87 (60.4)
Tumor budding (10-in-10) (n = 144) Low-grade 78 (54.2)
High-grade 66 (45.8)
Survival (n = 144) 5-year survival rate % (95%CI) 42.5 (26–58)